Klaria Pharma (Sweden) Volatility
| KLAR Stock | SEK 0.40 0.02 5.26% |
Currently, Klaria Pharma Holding is out of control. Klaria Pharma Holding has Sharpe Ratio of 0.0046, which conveys that the firm had a 0.0046% return per unit of risk over the last 3 months. We have found thirty technical indicators for Klaria Pharma, which you can use to evaluate the volatility of the firm. Please verify Klaria Pharma's Risk Adjusted Performance of 0.0157, mean deviation of 5.21, and Downside Deviation of 9.09 to check out if the risk estimate we provide is consistent with the expected return of 0.0368%. Key indicators related to Klaria Pharma's volatility include:
330 Days Market Risk | Chance Of Distress | 330 Days Economic Sensitivity |
Klaria Pharma Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Klaria daily returns, and it is calculated using variance and standard deviation. We also use Klaria's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Klaria Pharma volatility.
Klaria |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Klaria Pharma can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Klaria Pharma at lower prices. For example, an investor can purchase Klaria stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Klaria Pharma's stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.
Moving against Klaria Stock
Klaria Pharma Market Sensitivity And Downside Risk
Klaria Pharma's beta coefficient measures the volatility of Klaria stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Klaria stock's returns against your selected market. In other words, Klaria Pharma's beta of -1.82 provides an investor with an approximation of how much risk Klaria Pharma stock can potentially add to one of your existing portfolios. Klaria Pharma Holding is showing large volatility of returns over the selected time horizon. Klaria Pharma Holding is a potential penny stock. Although Klaria Pharma may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Klaria Pharma Holding. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Klaria instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
3 Months Beta |Analyze Klaria Pharma Holding Demand TrendCheck current 90 days Klaria Pharma correlation with market (Dow Jones Industrial)Klaria Beta |
Klaria standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 7.94 |
It is essential to understand the difference between upside risk (as represented by Klaria Pharma's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Klaria Pharma's daily returns or price. Since the actual investment returns on holding a position in klaria stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Klaria Pharma.
Klaria Pharma Holding Stock Volatility Analysis
Volatility refers to the frequency at which Klaria Pharma stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Klaria Pharma's price changes. Investors will then calculate the volatility of Klaria Pharma's stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Klaria Pharma's volatility:
Historical Volatility
This type of stock volatility measures Klaria Pharma's fluctuations based on previous trends. It's commonly used to predict Klaria Pharma's future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Klaria Pharma's current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Klaria Pharma's to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Klaria Pharma Holding Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
Klaria Pharma Projected Return Density Against Market
Assuming the 90 days trading horizon Klaria Pharma Holding has a beta of -1.8204 . This indicates as returns on its benchmark rise, returns on holding Klaria Pharma Holding are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Klaria Pharma is expected to outperform its benchmark.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Klaria Pharma or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Klaria Pharma's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Klaria stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Klaria Pharma Holding has an alpha of 0.2789, implying that it can generate a 0.28 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Predicted Return Density |
| Returns |
What Drives a Klaria Pharma Price Volatility?
Several factors can influence a stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Klaria Pharma Stock Risk Measures
Assuming the 90 days trading horizon the coefficient of variation of Klaria Pharma is 21600.02. The daily returns are distributed with a variance of 63.04 and standard deviation of 7.94. The mean deviation of Klaria Pharma Holding is currently at 5.18. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.77
α | Alpha over Dow Jones | 0.28 | |
β | Beta against Dow Jones | -1.82 | |
σ | Overall volatility | 7.94 | |
Ir | Information ratio | -0.0078 |
Klaria Pharma Stock Return Volatility
Klaria Pharma historical daily return volatility represents how much of Klaria Pharma stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The firm accepts 7.9396% volatility on return distribution over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.7626% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About Klaria Pharma Volatility
Volatility is a rate at which the price of Klaria Pharma or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Klaria Pharma may increase or decrease. In other words, similar to Klaria's beta indicator, it measures the risk of Klaria Pharma and helps estimate the fluctuations that may happen in a short period of time. So if prices of Klaria Pharma fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.Klaria Pharma Holding AB develops treatment methods in the therapeutic fields of migraine and pain related to cancer worldwide. Klaria Pharma Holding AB was founded in 2014 and is based in Uppsala, Sweden. Klaria Pharma is traded on Stockholm Stock Exchange in Sweden.
Klaria Pharma's stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Klaria Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Klaria Pharma's price varies over time.
3 ways to utilize Klaria Pharma's volatility to invest better
Higher Klaria Pharma's stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Klaria Pharma Holding stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Klaria Pharma Holding stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Klaria Pharma Holding investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Klaria Pharma's stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Klaria Pharma's stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Klaria Pharma Investment Opportunity
Klaria Pharma Holding has a volatility of 7.94 and is 10.45 times more volatile than Dow Jones Industrial. 70 percent of all equities and portfolios are less risky than Klaria Pharma. You can use Klaria Pharma Holding to enhance the returns of your portfolios. The stock experiences a very speculative upward sentiment. Check odds of Klaria Pharma to be traded at kr0.5 in 90 days.Good diversification
The correlation between Klaria Pharma Holding and DJI is -0.18 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Klaria Pharma Holding and DJI in the same portfolio, assuming nothing else is changed.
Klaria Pharma Additional Risk Indicators
The analysis of Klaria Pharma's secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Klaria Pharma's investment and either accepting that risk or mitigating it. Along with some common measures of Klaria Pharma stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | 0.0157 | |||
| Market Risk Adjusted Performance | (0.02) | |||
| Mean Deviation | 5.21 | |||
| Semi Deviation | 7.32 | |||
| Downside Deviation | 9.09 | |||
| Coefficient Of Variation | 11514.4 | |||
| Standard Deviation | 7.94 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Klaria Pharma Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Klaria Pharma as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Klaria Pharma's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Klaria Pharma's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Klaria Pharma Holding.
Additional Tools for Klaria Stock Analysis
When running Klaria Pharma's price analysis, check to measure Klaria Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Klaria Pharma is operating at the current time. Most of Klaria Pharma's value examination focuses on studying past and present price action to predict the probability of Klaria Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Klaria Pharma's price. Additionally, you may evaluate how the addition of Klaria Pharma to your portfolios can decrease your overall portfolio volatility.